Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Gatehouse Bio develops precision therapeutics by decoding small RNA isoforms and designing oligonucleotides that target disease-specific RNA signals. The company uses an AI-powered Code-Breaker…

Gatehouse Bio develops precision therapeutics by decoding small RNA isoforms and designing oligonucleotides that target disease-specific RNA signals. The company uses an AI-powered Code-Breaker…
Founded: 2020
Core tech: AI-driven small RNA (sRNA) analysis and oligonucleotide design (Code-Breaker platform)
Therapeutic focus: Pulmonary, cardiac, neurological, autoimmune indications
Headquarters / incubator: Waltham / AstraZeneca BioHub Incubator
Notable partners / investors: AstraZeneca (collaboration); investors include IndieBio, Front Row Fund, SOSV
Identification of disease-specific small RNA isoforms and design of precision oligonucleotide therapeutics.
2020
Biotechnology
Multiple convertible-note funding events reported in public databases; specific amounts not disclosed.
7945379
Last funding date reported in company snapshot metadata.
“Investors and accelerators associated include IndieBio, Front Row Fund, and SOSV; company site indicates it is seeking investors and lists strategic collaboration with AstraZeneca.”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week